AI in Medicine News ・ 💊 Drug discovery and clinical trials

AI Drug Discovery Gets a Virology Check: Why Respiratory Virus Polymerases Break the Benchmarks

Bioengineer.org · 10/16 20:21 UTC

A new review argues that AI-driven antiviral discovery must be benchmarked against respiratory RNA virus polymerases under virologically realistic conditions. It says this should be done rather than relying on docking scores.

Read the original (Bioengineer.org)

See it in the digest → ・ See this issue →